Tracy L Leong1,2, Paula M Loveland3, Alexandra Gorelik2,4, Louis Irving2,5, Daniel P Steinfort2,5. 1. The Walter and Eliza Hall Institute of Medical Research. 2. Department of Medicine, University of Melbourne. 3. Departments of General Medicine. 4. Institute for Health and Aging, Australian Catholic University, Melbourne, Vic., Australia. 5. Respiratory Medicine, Royal Melbourne Hospital, Parkville.
Abstract
BACKGROUND: Performance of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for staging the radiologically normal mediastinum has been reported with inconsistent findings. We assessed the sensitivity of systematic staging using EBUS-TBNA for detection of radiologically occult mediastinal metastases in cN0/N1 lung cancer. METHODS: Studies evaluating EBUS-TBNA for systematic mediastinal staging in cN0/N1 lung cancer were identified by systematic review. Data extracted included: participant age and sex; EBUS-TBNA protocol; stage determined by radiology, EBUS-TBNA and surgery; 2×2 tables. Primary outcome was diagnostic accuracy of EBUS-TBNA for detection of unsuspected N2/N3 disease. RESULTS: We identified 1173 articles. In total, 13 were included in a qualitative review and 9 (1146 patients) in a quantitative meta-analysis. Mean prevalence of N2/N3 disease was 15% (6% to 24%). EBUS-TBNA had pooled sensitivity of 49% [95% confidence interval (CI), 41%-57%], pooled specificity of 100% (95% CI, 99%-100%), mean negative predictive value 91% (82% to 100%) for detection of unsuspected N2/N3 metastases. Number needed to test to detect occult N2/N3 disease was 14 (95% CI, 10.8-16.3), which halved with addition of per-esophageal endoscopic ultrasound. CONCLUSION: Preoperative systematic staging by EBUS-TBNA of early lung cancer can reduce postoperative upstaging. Sensitivity for detection of radiologically occult mediastinal metastases seems lower than selective sampling of pathologic lymph nodes. Verification of negative results by mediastinoscopy in selected cases remains of value.
BACKGROUND: Performance of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for staging the radiologically normal mediastinum has been reported with inconsistent findings. We assessed the sensitivity of systematic staging using EBUS-TBNA for detection of radiologically occult mediastinal metastases in cN0/N1 lung cancer. METHODS: Studies evaluating EBUS-TBNA for systematic mediastinal staging in cN0/N1 lung cancer were identified by systematic review. Data extracted included: participant age and sex; EBUS-TBNA protocol; stage determined by radiology, EBUS-TBNA and surgery; 2×2 tables. Primary outcome was diagnostic accuracy of EBUS-TBNA for detection of unsuspected N2/N3 disease. RESULTS: We identified 1173 articles. In total, 13 were included in a qualitative review and 9 (1146 patients) in a quantitative meta-analysis. Mean prevalence of N2/N3 disease was 15% (6% to 24%). EBUS-TBNA had pooled sensitivity of 49% [95% confidence interval (CI), 41%-57%], pooled specificity of 100% (95% CI, 99%-100%), mean negative predictive value 91% (82% to 100%) for detection of unsuspected N2/N3 metastases. Number needed to test to detect occult N2/N3 disease was 14 (95% CI, 10.8-16.3), which halved with addition of per-esophageal endoscopic ultrasound. CONCLUSION: Preoperative systematic staging by EBUS-TBNA of early lung cancer can reduce postoperative upstaging. Sensitivity for detection of radiologically occult mediastinal metastases seems lower than selective sampling of pathologic lymph nodes. Verification of negative results by mediastinoscopy in selected cases remains of value.
Authors: Emily A DuComb; Benjamin A Tonelli; Ya Tuo; Bernard F Cole; Vitor Mori; Jason H T Bates; George R Washko; Raúl San José Estépar; C Matthew Kinsey Journal: Chest Date: 2020-06-26 Impact factor: 9.410
Authors: William R Kennedy; Pamela P Samson; Prashant Gabani; John Nikitas; Jeffrey D Bradley; Michael C Roach; Clifford G Robinson Journal: Radiother Oncol Date: 2020-07-03 Impact factor: 6.280
Authors: Javier Flandes; Luis Fernando Giraldo-Cadavid; Maria Teresa Perez-Warnisher; Andres Gimenez; Iker Fernandez-Navamuel; Javier Alfayate; Alba Naya; Pilar Carballosa; Elena Cabezas; Susana Alvarez; Ana Maria Uribe-Hernandez; Luis Seijo Journal: BMJ Open Date: 2022-10-19 Impact factor: 3.006
Authors: Maja Guberina; Ken Herrmann; Christoph Pöttgen; Nika Guberina; Hubertus Hautzel; Thomas Gauler; Till Ploenes; Lale Umutlu; Axel Wetter; Dirk Theegarten; Clemens Aigner; Wilfried E E Eberhardt; Martin Metzenmacher; Marcel Wiesweg; Martin Schuler; Rüdiger Karpf-Wissel; Alina Santiago Garcia; Kaid Darwiche; Martin Stuschke Journal: Sci Rep Date: 2022-10-20 Impact factor: 4.996
Authors: Gabriela Martinez-Zayas; Francisco A Almeida; Lonny Yarmus; Daniel Steinfort; Donald R Lazarus; Michael J Simoff; Timothy Saettele; Septimiu Murgu; Tarek Dammad; D Kevin Duong; Lakshmi Mudambi; Joshua J Filner; Sofia Molina; Carlos Aravena; Jeffrey Thiboutot; Asha Bonney; Adriana M Rueda; Labib G Debiane; D Kyle Hogarth; Harmeet Bedi; Mark Deffebach; Ala-Eddin S Sagar; Joseph Cicenia; Diana H Yu; Avi Cohen; Laura Frye; Horiana B Grosu; Thomas Gildea; David Feller-Kopman; Roberto F Casal; Michael Machuzak; Muhammad H Arain; Sonali Sethi; George A Eapen; Louis Lam; Carlos A Jimenez; Manuel Ribeiro; Laila Z Noor; Atul Mehta; Juhee Song; Humberto Choi; Junsheng Ma; Liang Li; David E Ost Journal: Chest Date: 2021-04-28 Impact factor: 10.262